Danaher (DHR) said late Thursday it is collaborating with AstraZeneca (AZN) to scale precision medicine, including developing AI-powered diagnostics.
The partnership would create a framework for diagnostics research, development and commercialization, Danaher said, adding that it will support the development cycle through its Centers for Enabling Precision Medicine.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。